Financial Performance - The total revenue for the reporting period was ¥482,499,222.60, representing a year-on-year increase of 13.46% compared to ¥425,261,940.98 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥51,568,565.10, an increase of 8.68% from ¥47,448,728.32 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥48,555,827.54, reflecting a growth of 12.36% compared to ¥43,216,294.13 in the same period last year[22]. - The total profit reached 63.95 million yuan, up 9.19% compared to the same period last year[53]. - The company reported a net profit for the first half of 2019 of ¥44.45 million, compared to ¥51.79 million in the first half of 2018, indicating a decrease of approximately 14.14%[151]. - The total comprehensive income for the first half of 2019 was ¥44.45 million, compared to ¥51.79 million in the first half of 2018, reflecting a decrease of approximately 14.14%[151]. Business Segments and Operations - The company has established four business segments: "Big Data and AI Medical Business," "Optoelectronic Business," "Smart Energy Technology Business," and "Intelligent Electrical Business," which require enhanced management capabilities[6]. - The company operates in four main business segments: Big Data and AI Medical Business, Optoelectronics, Energy Technology, and Smart Electrical Business, focusing on integrated solutions and innovative products[29][30][31]. - The company is focusing on three core business areas: third-party pathology testing services, automated tumor cell screening systems, and AI-assisted diagnostic systems[39]. - The company has developed a comprehensive tumor precision diagnosis service network, integrating online and offline services to enhance its market position in the healthcare sector[29][31]. - The company is expanding its smart energy technology business to provide energy management services through its software platform[38]. Innovation and R&D - The company emphasizes the importance of innovation and continuous product development to maintain market competitiveness[7]. - The company has established two academician expert workstations to drive technological and integrated innovation, enhancing product development across its business segments[33]. - The company has obtained 9 invention patents, 6 utility model patents, and 11 software copyrights related to AI products, reflecting its ongoing innovation efforts[45]. - The company is focusing on AI-assisted diagnostic products, which have become a new highlight of its business[52]. - The AI-assisted diagnostic system has launched products for malaria detection, tuberculosis screening, and oral cancer screening, aiming to improve healthcare service levels[34]. Financial Management and Risks - The company plans to not distribute cash dividends or issue bonus shares, indicating a focus on reinvestment[9]. - The company faces risks related to technological updates and product development, which could impact its market position if not managed effectively[7]. - The company has a commitment to adapt to regulatory changes in the industry to mitigate operational risks[5]. - The company will implement measures to mitigate risks from currency fluctuations by using hedging tools and adjusting contracts with clients[88]. - The company has a proactive approach to managing operational risks by strengthening internal controls and governance structures[86]. Market Presence and Sales - Approximately 50% of the company's sales revenue comes from international markets, making it susceptible to foreign exchange fluctuations[88]. - The sales model includes direct sales and distribution, with a focus on the education and biomedical markets[36]. - The company has developed the "Motic EasyScan Go," the world's first AI microscope for malaria detection, in collaboration with the Bill and Melinda Gates Foundation[34]. - The smart energy management platform has registered 1,300 users and provided 151 energy efficiency analysis reports, showcasing the company's commitment to energy internet construction[47]. Legal and Compliance - The company’s financial report is guaranteed to be true, accurate, and complete by its management, ensuring accountability[3]. - The company is committed to complying with the disclosure requirements for medical device businesses as per the Shenzhen Stock Exchange guidelines[58]. - The company is involved in a significant arbitration case with a supplier, involving a disputed amount of 64.205 million yuan related to accounts receivable[97]. - The company has initiated legal proceedings to revoke the arbitration and has submitted the case to the Shenzhen Intermediate People's Court for review[99]. Shareholder Information - There were no significant changes in shareholding structure, with total shares remaining at 510,163,336[117]. - The largest shareholder, MacAudie Holdings Limited, held 40.96% of shares, totaling 208,762,140 shares[120]. - The total number of ordinary shareholders at the end of the reporting period was 13,908[119]. - The company did not engage in any major related party transactions during the reporting period[102]. Asset and Liability Management - The total assets at the end of the reporting period were ¥1,489,181,870.62, which is a 3.55% increase from ¥1,438,161,162.39 at the end of the previous year[22]. - The total liabilities amounted to CNY 526,431,377.33, slightly up from CNY 522,851,459.54 at the end of 2018[137]. - The company's total liabilities to equity ratio was approximately 0.55, indicating a stable leverage position[137]. - Cash and cash equivalents at the end of the reporting period were CNY 410,222,835.20, a decrease of 5.19% from CNY 470,871,084.52 in the previous year[71].

Financial Performance - Total operating revenue for Q1 2019 was ¥221,000,338.38, an increase of 23.91% compared to ¥178,355,823.62 in the same period last year[7] - Net profit attributable to shareholders was ¥20,185,250.00, representing a 78.89% increase from ¥11,283,541.06 year-on-year[7] - Net profit excluding non-recurring gains and losses was ¥18,987,979.10, up 79.74% from ¥10,564,144.67 in the previous year[7] - Basic earnings per share increased to ¥0.0396, up 78.38% from ¥0.0222 in the previous year[7] - The operating profit reached 24.09 million CNY, a year-on-year increase of 90.46%[17] - The total profit amounted to 24.07 million CNY, reflecting an increase of 88.47% year-on-year[17] - The net profit attributable to shareholders was 20.19 million CNY, up 78.89% from the previous year[17] - The net profit for Q1 2019 reached CNY 19,463,564.10, representing a 92% increase from CNY 10,144,750.59 in Q1 2018[41] - The net profit for Q1 2019 reached CNY 7,063,174.69, representing a growth of 72.0% from CNY 4,106,074.93 in Q1 2018[45] Cash Flow - Net cash flow from operating activities reached ¥19,238,056.09, a significant increase from a negative cash flow of ¥462,039.86 in the same period last year, marking a 4,263.72% change[7] - Cash flow from operating activities generated a net amount of CNY 19,238,056.09, a significant improvement from a negative CNY 462,039.86 in the same quarter last year[49] - Total cash inflow from operating activities reached ¥73,359,854.97, up from ¥66,317,633.90 year-over-year[53] - The company reported a net cash flow from investing activities of -¥7,252,887.21, compared to a positive cash flow of ¥16,169,512.80 in the prior year[54] - Cash inflow from financing activities totaled ¥20,000,000.00, an increase from ¥14,500,000.00 in the previous year[54] - The net cash flow from financing activities was ¥7,766,761.15, down from ¥14,500,000.00 year-over-year[54] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,450,788,655.97, a 0.88% increase from ¥1,438,161,162.39 at the end of the previous year[7] - The total assets of the company were reported at ¥1,450,788,655.97, up from ¥1,438,161,162.39[31] - Total liabilities as of March 31, 2019, were ¥523,633,442.11, a slight increase from ¥522,851,459.54[32] - Non-current liabilities decreased to ¥305,895,523.71 from ¥315,983,267.76, reflecting a reduction of about 3.4%[32] - The total liabilities amounted to ¥522,851,459.54, indicating a stable financial position[58] - Total liabilities reached 427,199,327.58, consisting of current liabilities of 121,052,378.64 and non-current liabilities of 306,146,948.94[60] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,033[11] - The top shareholder, 麦克奥迪控股有限公司, held 40.92% of the shares, amounting to 208,762,140 shares[11] - The company's equity attributable to shareholders increased to CNY 673,785,605.74 from CNY 666,722,431.05, reflecting a growth of 1.6%[38] - The total equity attributable to shareholders was ¥864,881,117.77, remaining unchanged from the previous reporting period[58] Operational Metrics - The company's short-term borrowings decreased to 0 CNY, a reduction of 4.5 million CNY, representing a 100% decline[1] - The balance of other current assets increased to 6.39 million CNY, a growth of 45.06% due to an increase in deductible input tax[1] - The balance of prepayments at the end of the reporting period was 11.88 million CNY, an increase of 40.29% attributed to higher prepayments for equipment and molds[1] - Accounts receivable decreased to ¥255,699,040.20 from ¥266,620,820.12, with accounts receivable specifically dropping from ¥248,511,572.29 to ¥227,986,620.39[30] - Inventory increased to ¥244,537,661.13 from ¥222,314,243.25, indicating a growth of approximately 10%[30] Research and Development - Research and development expenses for Q1 2019 were CNY 11,122,374.45, compared to CNY 9,249,514.23 in the previous year, an increase of 20.2%[39] - Research and development expenses for Q1 2019 were CNY 3,948,326.68, slightly up from CNY 3,792,931.17 in the previous year[43] Risk Management and Future Plans - The company plans to enhance risk awareness and management across financial, supply chain, and intellectual property dimensions in response to complex external environments[16] - The company aims to strengthen internal control and risk management to ensure effective integration and management of acquired companies, minimizing integration risks[20] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[46] Compliance and Reporting - The company reported no violations regarding external guarantees during the reporting period[24] - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[25] - The company has not yet audited the first quarter report, which may affect the reliability of the financial data presented[61] - The company has implemented new financial instrument and lease standards, which may impact future financial reporting[61]

Financial Performance - The company achieved a revenue of 510,163,336 RMB for the year 2018, with a cash dividend of 0.58 RMB per 10 shares proposed for distribution to shareholders [11]. - The company's operating revenue for 2018 was approximately ¥978.8 million, representing a year-over-year increase of 13.30% compared to ¥863.9 million in 2017 [22]. - Net profit attributable to shareholders for 2018 was approximately ¥147.8 million, reflecting a growth of 9.32% from ¥135.2 million in 2017 [22]. - The total assets at the end of 2018 amounted to approximately ¥1.44 billion, a 1.99% increase from ¥1.41 billion at the end of 2017 [22]. - The net assets attributable to shareholders decreased by 20.98% to approximately ¥864.9 million from ¥1.09 billion in 2017 [22]. - The company reported a net cash flow from operating activities of approximately ¥155.0 million, down 8.51% from ¥169.4 million in 2017 [22]. - The total profit reached 180.15 million yuan, growing by 13.66% compared to the previous year [36]. - The company achieved total revenue of RMB 97,879.99 million, representing a year-on-year growth of 13.30% [62]. - Net profit attributable to shareholders was RMB 14,777.07 million, reflecting a year-on-year growth of 9.32% [62]. - The company reported a revenue of 140,482,598 RMB from its medical diagnostics segment, contributing to a net profit of 23,547,411.7 RMB [117]. Business Segments - The company operates four business segments: optical business, medical business, electrical business, and energy business, which require enhanced management capabilities [6]. - The company operates in four business segments: optical business, medical business, electrical business, and smart energy business [32]. - The optical business focuses on the development and sales of optical microscopes and digital imaging systems, targeting education, scientific research, and biomedical fields [33]. - The medical business provides integrated systems for tumor pathology diagnosis and personalized precision medicine, leveraging big data and AI for diagnostic support [34]. - The company is focusing on smart energy management and comprehensive energy services, enhancing energy efficiency and reducing costs for clients [36]. - The revenue from medical diagnostic products and services reached ¥140.2 million, a significant increase of 58.03% compared to ¥88.7 million in 2017 [77]. - The revenue from the electrical products segment was approximately ¥433.2 million, accounting for 44.26% of total revenue, with a growth of 9.70% year-on-year [76]. - The microscope manufacturing segment generated approximately ¥405.4 million, representing 41.42% of total revenue, with a year-on-year increase of 6.61% [76]. Acquisitions and Mergers - The company has expanded its business through acquisitions, including the cash acquisition of Motic Medical, which is expected to lead to further mergers and acquisitions [8]. - The company completed the acquisition of 80% of Medi Medical, making it a wholly-owned subsidiary, which has become a significant part of the company's operations [37]. - The company acquired 100% equity of Gelpag Advanced Technology GmbH for ¥2,934,870.80 on March 28, 2018 [84]. - The company acquired 100% of 麦克奥迪（厦门）医疗诊断系统有限公司 on June 8, 2018, which is expected to positively impact overall performance [117]. - The acquisition of 80% equity in Maidi Medical Diagnostic Systems Co., Ltd. was expected to yield CNY 15 million, with actual performance at CNY 23.38 million, also surpassing forecasts [149]. Innovation and R&D - The company emphasizes innovation and self-research as key development paths, facing risks related to technology updates and product development [9]. - The company’s commitment to continuous product and technology innovation is crucial for maintaining market competitiveness [9]. - The company is focusing on developing AI-assisted diagnostic systems to improve accuracy and reduce workload for pathologists [48]. - The company is integrating new technologies and materials into its products to enhance their technological value and maintain market competitiveness [37]. - The company has established partnerships with several universities and research institutions, enhancing its R&D capabilities and accelerating product updates [92]. - The R&D investment for 2018 amounted to approximately ¥57.33 million, representing 5.86% of the operating revenue, an increase from 5.27% in 2017 [95]. - The company has launched new medical products, including a series of digital slice scanners and intelligent microscopes, to meet market demands [94]. Market Exposure and Risks - Approximately 50% of the company's total revenue comes from overseas markets, indicating significant exposure to foreign exchange risks [10]. - The company’s financial performance may be adversely affected by fluctuations in exchange rates between the RMB and foreign currencies [10]. - The macroeconomic environment remains complex, with risks associated with economic transformation and structural adjustments impacting industry market capacity [5]. - The company is subject to operational management risks due to the complexity of its diversified business model [7]. - The company aims to address potential risks from national policy adjustments and macroeconomic changes by closely monitoring policy shifts and leveraging its business cycle differences [127]. Corporate Governance and Management - The company has established a robust internal management and control system to enhance corporate governance and protect shareholder rights [182]. - A scientific and standardized incentive system is being established to optimize human resource management and attract high-quality talent [67]. - The company is committed to strengthening its management structure and internal controls to address operational risks associated with its expanded business model [128]. - The company emphasizes the importance of fine management to improve operational efficiency and adapt to market changes [124]. Shareholder Information and Dividends - The company has a cash dividend policy that mandates at least 20% of the annual distributable profit to be distributed as cash dividends [135]. - The total cash dividend for the reporting period amounted to approximately ¥29.59 million, representing 100% of the profit distribution total [137]. - The cash dividend per 10 shares is ¥0.58, with a total of 510,163,336 shares as the basis for distribution [136]. - The company has maintained a consistent dividend payout ratio over the past three years, with 20.76% in 2017 and 18.43% in 2016 [145]. - The company’s remaining undistributed profits will be reserved for future distribution [140]. Social Responsibility - The company actively participated in social responsibility initiatives, including donations for medical equipment in impoverished areas [183]. - The company plans to continue its commitment to poverty alleviation through capital and social support initiatives in the future [185].

Financial Performance - Operating revenue for the reporting period was ¥267,651,176.18, representing a year-on-year increase of 23.93%[7] - Net profit attributable to shareholders increased by 38.83% to ¥47,792,304.06 for the reporting period[7] - Basic earnings per share rose by 38.20% to ¥0.0937[7] - The weighted average return on net assets was 4.99%, an increase of 1.58% compared to the same period last year[7] - The company reported a significant increase in revenue for Q3 2018, with a year-over-year growth of 25%[22] - Net profit for Q3 2018 was ¥48,515,963.68, representing a growth of 38.06% from ¥35,117,782.99 in Q3 2017[43] - The company achieved an operating profit of ¥57,214,579.19, which is a 38.76% increase from ¥41,247,182.50 in the previous year[43] - Total operating revenue for the current period reached ¥692,913,117.16, an increase of 13.6% compared to ¥609,653,998.46 in the previous period[50] - Net profit for the current period was ¥95,943,863.36, representing a 6.5% increase from ¥90,545,983.58 in the previous period[51] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,431,294,861.65, an increase of 1.51% compared to the end of the previous year[7] - Net assets attributable to shareholders decreased by 25.46% to ¥818,247,762.54 compared to the end of the previous year[7] - The company's total assets increased significantly, with construction in progress rising by 1280.48% to 2,379.13 million CNY compared to December 31, 2017[18] - Total liabilities increased significantly to CNY 563,781,984.45 from CNY 205,851,160.59, marking a rise of approximately 173.5%[36] - The company's equity attributable to shareholders decreased to CNY 818,247,762.54 from CNY 1,097,790,295.77, a decline of about 25.5%[36] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥86,461,046.67, a decrease of 20.47% compared to the same period last year[7] - The total cash inflow from operating activities was CNY 704,586,422.94, an increase of 9.34% compared to CNY 644,437,381.77 in the previous period[56] - The net cash flow from operating activities decreased to CNY 86,461,046.67, down 20.43% from CNY 108,708,517.81 in the previous period[56] - The cash inflow from financing activities was CNY 228,525,000.00, up from CNY 72,600,000.00 in the previous period, reflecting a strong increase in financing[58] - The net cash flow from financing activities increased to CNY 168,376,622.50, compared to CNY 47,016,688.24 in the previous period, showing improved financing conditions[58] Shareholder Information - The company reported a total of 18,203 common shareholders at the end of the reporting period[11] - The top shareholder, MacAudie Holdings Limited, holds 40.92% of the shares, totaling 208,762,140 shares[11] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[12] Investment and Expenses - The company's financial expenses for the first nine months of 2018 were -565.68 million CNY, an increase of 536.18% year-on-year, primarily due to increased foreign exchange gains from the appreciation of the US dollar[19] - Investment income decreased by 423.63% year-on-year to -199.43 million CNY, mainly due to losses from foreign exchange forward contracts[19] - Research and development expenses increased to ¥15,885,551.02, up 25.00% from ¥12,624,825.11 in the same quarter last year[41] - Research and development expenses increased to ¥34,387,938.14, up 21.8% from ¥28,241,199.83 in the prior period[50] Market Outlook and Strategy - The company provided a positive outlook for the next quarter, projecting a revenue increase of 20% based on current market trends[24] - New product development is underway, with two innovative products expected to launch in Q4 2018, targeting a market share increase of 10%[25] - The company is expanding its market presence in Southeast Asia, aiming for a 30% increase in sales in that region by the end of 2019[26] - A strategic acquisition of a local competitor is in progress, which is anticipated to enhance the company's product offerings and customer base[27] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[41] Compliance and Governance - There were no violations regarding external guarantees during the reporting period, ensuring financial stability[27] - The company has no non-operating fund occupation by controlling shareholders or related parties during the reporting period[29] - The management emphasized the importance of adhering to non-competition agreements to avoid conflicts with existing business operations[23]

Financial Performance - Total revenue for the first half of 2018 was CNY 425,261,940.98, representing an increase of 8.02% compared to CNY 393,686,895.20 in the same period last year[17]. - Net profit attributable to shareholders decreased by 13.62% to CNY 47,448,728.32 from CNY 54,932,838.16 year-on-year[17]. - Net profit after deducting non-recurring gains and losses fell by 16.67% to CNY 43,216,294.13 compared to CNY 51,861,738.56 in the previous year[17]. - Basic earnings per share decreased to CNY 0.0932, down 13.62% from CNY 0.1079[17]. - The company achieved total revenue of 425.26 million yuan, a year-on-year increase of 8.02%, while net profit attributable to shareholders decreased by 13.62% to 47.45 million yuan[27]. - The company reported a total of CNY 4,232,434.19 in non-recurring gains and losses for the reporting period[21]. - The weighted average return on net assets was 5.11%, a decrease of 0.43% compared to 5.54% in the previous year[17]. - The company reported a significant increase in construction in progress, with a year-end balance of RMB 12.73 million, representing a growth of 638.85% compared to the beginning of the year, primarily due to investments in new factory construction[42]. - The company reported a significant increase in short-term borrowings, amounting to ¥40,000,000.00, which was not present at the beginning of the period[156]. - The company reported a net loss attributable to shareholders of 28,047,986.33 yuan during the period[187]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,430,542,485.70, an increase of 1.46% from CNY 1,409,980,994.66 at the end of the previous year[17]. - Net assets attributable to shareholders decreased by 30.83% to CNY 759,321,977.46 from CNY 1,097,790,295.77 at the end of the previous year[17]. - The company's total liabilities increased significantly to ¥625,129,053.20 from ¥205,851,160.59, indicating a rise of approximately 203.5%[156]. - The company's total equity decreased to ¥805,413,432.50 from ¥1,204,129,834.07, indicating a decline of about 33.1%[157]. - Cash and cash equivalents at the end of the reporting period were ¥527.80 million, representing 36.90% of total assets, a decrease of 4.61% from the previous year[71]. - Accounts receivable increased to ¥205.09 million, accounting for 14.34% of total assets, up from 12.71% year-on-year[71]. - Inventory rose to ¥223.19 million, representing 15.60% of total assets, an increase from 13.37% in the previous year[72]. Business Strategy and Operations - The main business model has shifted to a dual focus on "electrical equipment manufacturing + energy internet and optical instrument manufacturing + internet healthcare" through acquisitions and resource integration[24]. - The company is enhancing its epoxy insulation products, which are critical components in electrical equipment, to improve data collection capabilities and support the transition to an energy internet[25]. - The optical microscope series products are widely used in education, research, and biomedical fields, integrating advanced technologies for enhanced imaging capabilities[26]. - The internet healthcare services focus on tumor diagnosis and include a digital slice scanning system, providing integrated services for tumor screening and diagnosis[26]. - The company employs a "make-to-order" production model for its epoxy insulation products, ensuring customization based on client specifications[28]. - The sales strategy includes direct sales and distribution, with a focus on high education markets domestically and leveraging distributors internationally[32]. - The company is leveraging big data and AI technologies to create a comprehensive solution for tumor diagnosis, integrating screening, diagnosis, and treatment consultation[33]. - The company has developed an integrated system for automatic quantitative analysis of cell DNA, which enhances sensitivity and objectivity in early tumor detection, reducing misdiagnosis rates[34]. - The digital slide scanning system allows for seamless stitching of images to create whole slide imaging (WSI), facilitating remote consultations and educational purposes[34]. - The company is focusing on personalized cancer treatment consultations based on genetic research and updated treatment guidelines, aiming to reduce misdiagnosis and improve patient outcomes[38]. Research and Development - Management and sales expenses increased by 1.22 million yuan and 644,290 yuan respectively, primarily due to increased R&D and market investments in new business areas[27]. - The company is focusing on enhancing its R&D capabilities while actively seeking collaboration with external professional R&D teams for new technology and product development[60]. - The company is committed to increasing R&D investment to address risks associated with international trade tensions and domestic economic adjustments[57]. - The company has obtained a total of 102 invention patents, 109 utility model patents, 85 software copyrights, and design patents, showcasing its commitment to technological innovation[43]. Market Expansion and Acquisitions - The company completed the acquisition of 80% of Motic Medical for RMB 432 million, becoming its 100% shareholder, marking a strategic shift towards integrating traditional optical equipment manufacturing with healthcare services[50]. - The company has formed long-term strategic partnerships with clients across various countries, including the United States, Germany, and Japan, with many clients maintaining relationships for over 20 years[45]. - The company plans to expand its third-party clinical laboratories and pathology diagnostic centers in cities like Yinchuan, Shanghai, and Henan, enhancing its service network[40]. - The company is actively pursuing smart switch products and intelligent grid construction as part of its transition to the energy internet[54]. - The company plans to expand its international market presence through e-commerce and is shifting towards B2C sales models for microscope products[53]. Risk Management - The company faces management risks due to rapid expansion, requiring improvements in organizational structure and management systems[92]. - The company is committed to not engage in any competitive business activities with its shareholders and related parties[105]. - The company faces risks including national policy adjustments and macroeconomic changes, which may lead to subdued market demand or intensified competition[90]. - The company has implemented a stock incentive plan, with 2.1 million shares eligible for unlocking, representing 0.41% of the total share capital[113]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,877[138]. - The largest shareholder, MacAudie Holdings Limited, holds 40.92% of the shares, totaling 208,762,140 shares[139]. - The company’s shareholding structure includes 72.69% of unrestricted shares and 27.31% of restricted shares[130]. - The total number of shares decreased from 510,211,336 to 510,163,336 due to the repurchase and cancellation of 48,000 restricted shares[131].

2018 年 04 月 1 麦克奥迪（厦门）电气股份有限公司 2018 年第一季度报告全文 麦克奥迪（厦门）电气股份有限公司 2018 年第一季度报告 2018-031 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 麦克奥迪（厦门）电气股份有限公司 2018 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人杨泽声、主管会计工作负责人胡春华及会计机构负责人(会计主 管人员)郭春碧声明：保证季度报告中财务报表的真实、准确、完整。 2 麦克奥迪（厦门）电气股份有限公司 2018 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 3 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业总收入（元） | 165,310,494.35 | 166,051,265.79 | -0.45% | | 归属于上市公司股东的净利润（ ...

Financial Performance - The company reported a revenue of approximately 510 million RMB for the year 2017, with a cash dividend of 0.55 RMB per 10 shares[12]. - The company's total revenue for 2017 was ¥795,534,210.47, representing an 8.7% increase compared to ¥731,874,211.37 in 2016[23]. - Net profit attributable to shareholders for 2017 was ¥130,324,230.52, a 14.65% increase from ¥113,668,876.30 in 2016[23]. - The net cash flow from operating activities increased by 42.90% to ¥161,469,559.43 in 2017, up from ¥112,991,329.47 in 2016[23]. - The company reported a total profit of ¥15,077,190.00 for 2017, which is a 10.23% increase compared to the previous year[32]. - The company’s net profit after deducting non-recurring gains and losses was ¥124,327,454.34, marking a 15.66% increase from ¥107,491,077.18 in 2016[23]. - The total distributable profit for the year 2017 was CNY 126,239,050.80 after allocating CNY 4,085,179.72 to the statutory surplus reserve[125]. - The company proposed a cash dividend of CNY 0.55 per 10 shares, totaling CNY 28,058,983.48 (including tax) for the year 2017[124]. - The cash dividend distribution accounted for 100% of the total profit distribution for the year 2017[124]. - The company’s cash dividend policy mandates that at least 20% of the distributable profit must be distributed as cash dividends in profitable years[122]. Market Exposure and Risks - The foreign market sales accounted for about 50% of the total revenue, indicating significant exposure to currency fluctuations[10]. - The company faces risks related to economic cycles, particularly in the epoxy insulation products sector, which is closely tied to the power equipment industry[5]. - The company has a risk of talent loss, particularly in key positions, which could impact long-term development[9]. - The market for epoxy insulation products is highly competitive, with many small enterprises lacking effective competitive capabilities[37]. - The company faces cyclical risks due to its reliance on the power equipment industry, which is significantly affected by macroeconomic conditions[112]. Acquisitions and Subsidiaries - The company has expanded its subsidiaries through acquisitions, including Motic Optical and Beijing Kairui Energy Technology, increasing management complexity[8]. - The company has completed several acquisitions in recent years, which may pose integration and goodwill impairment risks[12]. - The company acquired 63.82% of Beijing Kairui Energy Technology Co., Ltd. for RMB 50 million, and established a new subsidiary in Shenyang with a 51% stake[50]. - The company established a new subsidiary, Shenyang Miko Energy Technology Co., Ltd., with a 51% ownership and a registered capital of ¥10 million[70]. - The company acquired 63.82% of Beijing Kairui Energy Technology Co., Ltd. for a cash consideration of ¥50 million, with the acquisition date set as December 31, 2017[69]. Innovation and Technology - The company emphasizes continuous investment in technology innovation and new product development to maintain market leadership[6]. - The company has established partnerships with authoritative research institutions and universities to enhance its innovation capabilities[7]. - The company holds 7 invention patents and 33 utility model patents in the epoxy insulation sector, ensuring technological leadership[41]. - The optical microscope business has obtained 50 invention patents and 65 utility model patents, maintaining industry-leading technology[42]. - The company is committed to continuous innovation and product development to adapt to changing market demands and improve core competitiveness[52]. Management and Operational Efficiency - The company emphasizes management innovation and lean management to improve cost efficiency and management levels[34]. - The company has established a robust internal control system to improve operational efficiency and risk management[59]. - The management team consists of experienced professionals with deep industry understanding, enhancing operational efficiency and customer service[44]. - The company aims to enhance its management efficiency by improving the SAP system and implementing performance evaluations and monthly meetings, which effectively control operational costs[106]. - The company has established an integrated management system under ISO standards, significantly improving management quality and efficiency[106]. Customer Base and Sales Strategy - The company has established a stable customer base, with many clients maintaining partnerships for over 20 years, providing a strong foundation for sustainable development[46]. - The company adopts a direct sales model complemented by distributors, focusing on customer-centric marketing services[35]. - The company plans to enhance its marketing management system and focus on customer-centric strategies to drive new profit sources[56]. - The company is focusing on expanding its market presence in the energy internet sector as part of its strategic transformation[103]. Financial Management and Shareholder Relations - The company has a history of consistent cash dividend distribution, with a minimum of 20% of distributable profit allocated in the past three years[122]. - The company has committed to fulfilling all promises made by shareholders and related parties during the reporting period[129]. - The company has implemented a cash dividend policy to ensure shareholder returns[158]. - The company has not proposed a cash dividend distribution plan for the reporting period despite having positive distributable profits[129]. - The company has not engaged in any major related party transactions during the reporting period[146]. Employee and Governance - The company has a total of 1,861 employees, with 620 in the parent company and 1,241 in major subsidiaries[194]. - The company has implemented a stock incentive plan since 2015, benefiting over 80 employees, demonstrating its commitment to attracting and retaining core talent[196]. - The governance structure of the company complies with the requirements of the China Securities Regulatory Commission and the Shenzhen Stock Exchange, with no unresolved governance issues[200]. - The company has a diverse board with members having backgrounds in law, finance, and management[187]. - The remuneration for directors and senior management is determined based on the company's profitability and individual performance, ensuring alignment with shareholder interests[191].

Financial Performance - Net profit attributable to shareholders was ¥32,802,966.53, reflecting a growth of 4.65% year-on-year[7]. - Operating revenue for the reporting period was ¥205,551,435.79, up by 8.33% compared to the same period last year[7]. - Basic earnings per share were ¥0.0646, an increase of 4.53% year-on-year[7]. - The company reported a net profit attributable to shareholders of ¥87,117,807.50 for the year-to-date, which is a 23.83% increase compared to the same period last year[7]. - For the first nine months of 2017, the company achieved total operating revenue of 573.56 million yuan, an increase of 10.92% year-on-year[18]. - The operating profit for the same period was 99.97 million yuan, up 18.04% compared to the previous year[18]. - The net profit attributable to shareholders for the first nine months was 87.12 million yuan, reflecting a year-on-year increase of 23.83%[18]. - The total profit for Q3 2017 was 39.27 million yuan, up 4.92% from the same period last year[18]. - The company reported a comprehensive income total of ¥28,276,952.22 for the current period, down from ¥32,782,105.61 in the previous period[46]. - The total comprehensive income for the period was CNY 76,786,055.60, slightly up from CNY 75,359,473.39 in the previous period[54]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,234,073,184.81, an increase of 8.79% compared to the end of the previous year[7]. - The total liabilities of the company were CNY 169,158,146.45, compared to CNY 136,874,897.71 at the beginning of the period, marking an increase of about 23.4%[38]. - The equity attributable to the owners of the parent company reached CNY 1,049,030,706.92, up from CNY 991,307,755.53, reflecting an increase of approximately 5.8%[39]. - The company's non-current assets totaled CNY 424,289,355.96, slightly down from CNY 430,158,730.81[37]. - The total assets increased to ¥892,028,276.84 from ¥869,265,168.65 at the beginning of the period[42]. - The total liabilities increased to ¥82,853,842.33 from ¥74,046,675.36, indicating a rise of approximately 11.00%[42]. Cash Flow - The net cash flow from operating activities for the year-to-date reached ¥85,577,248.87, representing a significant increase of 43.92%[7]. - The cash flow from operating activities generated a net amount of ¥85.58 million, up from ¥59.46 million year-over-year, indicating a growth of about 43.9%[60]. - The cash outflow for operating activities was ¥490.76 million, compared to ¥471.21 million in the previous year, showing an increase of about 4.2%[60]. - The cash flow from investment activities resulted in a net outflow of approximately ¥15.23 million, a decrease from a net inflow of ¥23.97 million in the same period last year[61]. - The cash flow from financing activities showed a net outflow of approximately ¥15.78 million, compared to a net outflow of ¥24.20 million in the previous year, indicating an improvement[61]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,848[11]. - The largest shareholder, MacAudie Holdings Limited, holds 40.92% of the shares[11]. - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[12]. Market and Strategic Initiatives - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2018[27]. - A strategic acquisition of a local competitor is being considered, which could enhance the company's product offerings and market reach[24]. - New product development initiatives are underway, with an investment of approximately $5 million allocated for R&D in innovative technologies[26]. - The company provided a positive outlook for Q4 2017, projecting a revenue increase of 20% based on current market trends[25]. - Future guidance indicates a focus on sustainable growth, with plans to diversify product lines and enhance customer engagement strategies[23]. Operational Efficiency - The company aims to reduce operational costs by 15% through efficiency improvements in the supply chain[26]. - The management emphasized the importance of compliance with social security and housing fund regulations to avoid potential penalties[27]. User Engagement - User data showed an increase in active users by 15% compared to the previous quarter, reaching a total of 1.2 million active users[24].

Financial Performance - Total operating revenue for the reporting period was ¥368,008,364.77, an increase of 12.42% compared to ¥327,364,573.96 in the same period last year[17]. - Net profit attributable to shareholders was ¥54,314,840.98, representing a growth of 39.24% from ¥39,009,332.66 year-on-year[17]. - Net cash flow from operating activities reached ¥46,364,569.27, a significant increase of 224.70% compared to ¥14,279,293.38 in the previous year[17]. - Basic earnings per share rose to ¥0.1071, up 40.18% from ¥0.0764 in the same period last year[17]. - Total assets at the end of the reporting period were ¥1,169,916,348.67, reflecting a 3.14% increase from ¥1,134,340,170.31 at the end of the previous year[17]. - The company reported a weighted average return on equity of 5.40%, an increase of 1.17% from 4.23% in the previous year[17]. - The net profit after deducting non-recurring gains and losses was ¥52,142,838.02, a 35.17% increase from ¥38,575,968.00 in the same period last year[17]. - Operating profit increased to RMB 6,234.13 million, up 31.46% compared to the previous year[42]. - Total profit rose to RMB 6,490.40 million, reflecting a year-on-year increase of 35.43%[42]. - The company reported a half-year revenue of 1.5 billion RMB, representing a 15% increase compared to the same period last year[89]. Business Segments - The company operates in two main business segments: the research, production, and sales of epoxy insulation components, and optical microscopes and digital microscopes[24]. - The company operates a dual business model focusing on "epoxy insulation" and "optical microscopes," with the insulation segment closely tied to the development of power transmission and distribution equipment[30]. - The optical microscope products are widely applicable in life sciences, biomedical diagnostics, and industrial measurement, integrating advanced technologies[29]. - The company has established partnerships with several universities for R&D, improving product performance and reducing energy consumption[34]. - The company holds a total of 52 invention patents, 61 utility model patents, and 84 software copyrights, showcasing its strong R&D capabilities[34]. Market and Competition - The insulation industry is characterized by intense competition, with many small enterprises lacking competitive advantages, while a few companies maintain strong R&D capabilities[31]. - The projected growth in power transmission infrastructure indicates significant future market potential for epoxy insulation products[26]. - The company is adapting its sales model to meet increasing customization demands from domestic customers, aiming to enhance market share[28]. - The company is expanding its market presence in Southeast Asia, targeting a 25% market share in the region by 2025[93]. - The company holds a significant market share in the mid-to-high-end segments of the optical microscope and epoxy insulation industries, but faces increasing competition from various sectors[80]. Investment and Expansion - The establishment of Shenyang Motic Energy Technology Co., Ltd. with a registered capital of RMB 100 million aims to expand into the energy internet sector[42]. - The company plans to establish a pathology testing center in Shenyang, which has led to increased fixed asset investment, impacting short-term performance[63]. - The company has committed to investing 100 million RMB in R&D for new technologies over the next two years[95]. - The company has initiated new strategies for technology development and market expansion, aiming for a growth rate of 10% in the next fiscal year[171]. - The company plans to diversify its business to mitigate macroeconomic risks and enhance product innovation capabilities[77]. Financial Management - The company has strengthened its internal control systems to enhance operational efficiency and risk management[46]. - The company emphasizes quality control across its production processes, adhering to multiple international quality management standards[37]. - The company has implemented a refined management model to improve operational efficiency and reduce management costs[46]. - The financial expenses decreased by 55.74% due to reduced foreign exchange losses[48]. - The company aims to balance domestic and international markets to manage macroeconomic risks effectively[77]. Shareholder Information - The company will not distribute cash dividends or issue bonus shares for the half-year period, focusing on reinvestment instead[85]. - The total number of shareholders at the end of the reporting period is 17,257[124]. - The largest shareholder, MacAudi Holdings Limited, holds 40.92% of the shares, totaling 208,762,140 shares[125]. - The company has a total of 141,327,336 restricted shares at the beginning of the period, with 2,268,000 shares released during the period[126]. - The company completed the repurchase and cancellation of 120,000 restricted stocks due to the departure of one incentive object, reducing the total share capital from 510,331,336 shares to 510,211,336 shares[119]. Compliance and Governance - The company has committed to maintaining compliance with various promises made during its public offerings and restructuring processes, ensuring no violations occurred during the reporting period[86]. - The company reported no significant litigation or arbitration matters during the reporting period[97]. - There were no major penalties or rectification situations reported for the company during the reporting period[99]. - The company did not engage in any major related party transactions during the reporting period[101]. - The company has not been involved in any major environmental protection issues and is not listed as a key pollutant unit[113]. Future Outlook - The company expects a revenue growth guidance of 10% for the next quarter, projecting a total revenue of 1.65 billion RMB[91]. - New product development includes the launch of a smart energy management system, expected to contribute an additional 200 million RMB in revenue next year[92]. - The company recognizes the need for timely adaptation in product innovation and sales network development to maintain its market share and competitive edge[80]. - The company aims to enhance its brand and financial advantages by optimizing resources and expanding its business lines to improve profitability and risk resilience[80]. - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[171].

Financial Performance - Total revenue for Q1 2017 was ¥166,051,265.79, representing a 28.46% increase compared to ¥129,266,794.53 in the same period last year[7]. - Net profit attributable to shareholders was ¥20,205,413.35, a significant increase of 103.43% from ¥9,932,589.95 year-on-year[7]. - The net cash flow from operating activities reached ¥11,604,621.14, up 33.12% from ¥8,717,108.29 in the previous year[7]. - Basic earnings per share increased by 106.32% to ¥0.0392 from ¥0.0190 in the same period last year[7]. - Operating profit reached 23.79 million yuan, up 96.20% compared to the same period last year[24]. - The main driver for revenue growth was product sales revenue of 163.80 million yuan, which increased by 36.63 million yuan compared to the previous year[24]. - The total profit for the reporting period increased by 11,590,900 yuan compared to the same period last year, primarily due to an increase in operating income[22]. - The company achieved operating revenue of 731,874,211.37 yuan and a net profit attributable to shareholders of 113,668,876.30 yuan in Q1 2017[42]. - The proposed cash dividend is 0.5 yuan per 10 shares, totaling an estimated distribution of 25,510,566.80 yuan (tax included) to shareholders[42]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,145,175,231.97, a slight increase of 0.96% from ¥1,134,340,170.31 at the end of the previous year[7]. - The total liabilities decreased from 136,874,897.71 yuan to 128,688,241.05 yuan, indicating a reduction of about 6.5%[51]. - The company's total current assets reached 719,671,388.74 yuan, compared to 704,181,439.50 yuan at the start of the period, reflecting a growth of approximately 2.1%[49]. - The company's equity increased to ¥805,452,360.63 from ¥795,218,493.29[55]. - The cash and cash equivalents at the end of the period were CNY 215,397,592.61, down from CNY 297,684,427.84, indicating a decrease of about 27.6%[67]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,398[16]. - The largest shareholder, MacAudi Holdings Limited, holds 40.91% of shares, totaling 208,762,140 shares[16]. - The second largest shareholder, Hong Kong Xielihang Limited, holds 24.15% of shares, totaling 123,220,204 shares[16]. - The company did not conduct any repurchase transactions among the top 10 common shareholders during the reporting period[17]. Risks and Challenges - The company faces risks related to economic cycles, which could impact order volumes and sales performance[9]. - The company is exposed to foreign exchange risks, with nearly 50% of sales revenue coming from international markets[13]. - The company has expanded its management structure due to acquisitions, which necessitates effective management to mitigate risks[11]. - There are currently no significant risk factors affecting the company's future development strategy[24]. Investment and Projects - The APG epoxy insulation production expansion project has a total investment of 8,831 million CNY, with 4,336 million CNY invested by June 30, 2017, achieving 78.96% of the planned investment[37]. - The acquisition of a 20% stake in the medical diagnostic system of 麦克奥迪 (Xiamen) has a total investment of 10,500 million CNY, fully utilized as of December 15, 2016[37]. - The company has decided to suspend the "Metal Parts Processing Supporting Project" and reallocate the raised funds of 6,005 million yuan and 4,495 million yuan for acquiring 20% equity in Xiamen Medical Diagnostics[40]. - The completion date for the "APG Epoxy Insulation Product Expansion Project" has been postponed to June 30, 2017, due to equipment procurement and debugging delays[39]. Compliance and Commitments - The company has made commitments regarding stock options and financial support, which have been adhered to without violations[29]. - The company has received non-competition commitments from major shareholders to avoid conflicts of interest in future expansions[33]. - The company has confirmed that there are no relationships between its major clients and suppliers and its actual controller, ensuring operational independence[36]. - The company reported no violations regarding external guarantees or non-operating fund occupation by controlling shareholders during the reporting period[43][44].